Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
We recently published a list of 10 Best Big-Name Stocks to Buy Right ... selling on individual US-listed stocks […] A Phase 3 ...
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
Zacks.com on MSN4d
AZN Gets FDA Nod for Fasenra Label Expansion in Rare DiseaseThe FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...
Health and Me on MSN6d
GST Slashed On Three Cancer Drug: Here's How It Will Affect PatientsThe recent GST cut on cancer drugs could mean significant cost reductions for cancer treatment in India. Read to know how it ...
More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet. The new study by the Global Research ...
Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...
Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
GlobalData on MSN5d
Comparing the US’s ten most expensive drugs with prices in the UKPresident Donald Trump has made drug prices a core issue of his administration, causing consternation among US drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback